RTSM Resources
-
How Heron Therapeutics Sped Up Database Creation
12/2/2022
Electronic data capture (EDC) is straightforward, in theory. However, not every EDC is purpose-designed for ease of use by study teams, and some are easier to use and more intuitive than others.
-
What To Look For In Your IRT/RTSM Solution For A Simpler Trial Execution
10/4/2024
Which factors should you consider when selecting an IRT/RTSM vendor to ensure your trial's randomization and supply management processes are successfully executed?
-
How Long Is Your RTSM Risk Mitigation List?
11/21/2024
While RTSM systems help reduce many of the risks in clinical trials, each trial’s unique setup necessitates a risk analysis to identify trial-specific challenges.
-
Simple, Cost-Effective Ways To Engage Patients Using eCOA And IRT
9/7/2022
Today, patients are exposed to sophisticated technology, which presents a huge opportunity to elevate engagement. Consider some common elements when initiating engagement during clinical development.
-
Key Considerations For A Direct-to-Patient Clinical Trial
1/20/2022
This webinar explores important considerations for developing a Direct-to-Patient strategy and the RTSM features needed to support its execution.
-
RTSM: Randomization And Cohort Management, IP Inventory Management
4/17/2024
Signant’s SmartSignals® RTSM solution helped an innovative biopharmaceutical company secure an FDA Orphan Drug designation for its cardiomyopathy drug.
-
Top 5 Reasons You Need IRT Expertise (Not Just Software)
7/11/2022
Gain insight into why pharma companies generally seek IRT vendor relationships to ensure high-quality builds that meet their needs and avoid the potential pitfalls associated with RTSM.
-
Our Unified Platform Serves As eSource For COVID Treatment Trial
6/17/2024
Signant Biotech optimized technology for an emerging biopharmaceutical's Phase 2 COVID treatment trial in critically ill patients, minimizing paper data risks and streamlining consent and data management across multiple sites and solutions.
-
Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial
1/16/2024
Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
-
Bringing RTSM In From The Cold
11/2/2023
Watch James Stringer's presentation from the October 2023 Clinical Leader Solutions Expo: IRT Showcase to learn how site burden can be reduced by having more consolidated platforms.